Syndecan-1: A Novel Diagnostic and Therapeutic Target in Liver Diseases

被引：3
作者：
Zhang, Xiaoli [1 ,2 ]
Zhao, Yalei [1 ,2 ]
Liu, Liangru [1 ,2 ]
He, Yingli [1 ,2 ]
机构：
[1] Xi An Jiao Tong Univ, Dept Infect Dis, Affiliated Hosp 1, Xian, Peoples R China
[2] Coconstructed Natl Hlth Commiss PRC & Peoples Govt, Dept Pharm, Natl Reg Infect Dis Ctr, Xian, Peoples R China
来源：
CURRENT DRUG TARGETS | 2023年 / 24卷 / 15期
基金：
中国国家自然科学基金;
关键词：
Heparan sulfate proteoglycans; Syndecan-1; hepatocytes; myofibroblasts; liver diseases; HEPARAN-SULFATE PROTEOGLYCANS; GLYCOGEN-SYNTHASE KINASE-3; CELL-SURFACE PROTEOGLYCAN; GROWTH-FACTOR RECEPTOR; HEPATOCELLULAR-CARCINOMA; REDUCED EXPRESSION; CORE PROTEIN; SERUM-LEVELS; HELA-CELLS; ECTODOMAIN;
D O I：
10.2174/0113894501250057231102061624
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Syndecan-1 (SDC-1), known as a coreceptor of various growth factors or an integrin binding partner, regulates various cell behaviours. Under certain pathological conditions, SDC-1 is shed from the cell surface and plays a protective or pathogenic role in various diseases. In the liver, SDC-1 is highly expressed in hepatocytes, where it is localized on the basolateral surface. It is critical to the cellular and molecular functions of hepatocytes, including their attachment to hepatitis viruses. Previous studies have reported that SDC-1 may function as a novel and promising diagnostic and therapeutic marker for various liver diseases, such as drug-induced liver injury, liver fibrosis, and liver cancer. In this review, we summarize related research and highlight the mechanisms by which SDC-1 participates in the pathogenesis of liver diseases, as well as its potential diagnostic and therapeutic applications. This review is expected to lay the foundation for further therapeutic strategies to target SDC-1 in liver diseases.
引用
收藏
页码：1155 / 1165
页数：11
相关论文
共 100 条
  • [11] Expression of Syndecan-1 in Chronic Liver Diseases: Correlation With Hepatic Fibrosis
    Charchanti, Antonia
    Kanavaros, Panagiotis
    Koniaris, Efthymios
    Kataki, Agapi
    Glantzounis, Georgios
    Agnantis, Niki J.
    Goussia, Anna C.
    [J]. IN VIVO, 2021, 35 (01): : 333 - 339
  • [12] RANTES (CCL5) induces a CCR5-dependent accelerated shedding of syndecan-1 (CD138) and syndecan-4 from HeLa cells and forms complexes with the shed ectodomains of these proteoglycans as well as with those of CD44
    Charnaux, N
    Brule, S
    Chaigneau, T
    Saffar, L
    Sutton, A
    Hamon, M
    Prost, C
    Lievre, N
    Vita, C
    Gattegno, L
    [J]. GLYCOBIOLOGY, 2005, 15 (02) : 119 - 130
  • [13] Heparanase induces necroptosis of microvascular endothelial cells to promote the metastasis of hepatocellular carcinoma
    Chen, Xiaopeng
    Cheng, Bin
    Dai, Dafei
    Wu, Yuhai
    Feng, Zhiwen
    Tong, Chaogang
    Wang, Xiangming
    Zhao, Jun
    [J]. CELL DEATH DISCOVERY, 2021, 7 (01)
  • [14] Secreted neutral metalloproteases of Bacillus anthracis as candidate pathogenic factors
    Chung, Myung-Chul
    Popova, Taissia G.
    Millis, Bryan A.
    Mukherjee, Dhritiman V.
    Zhou, Weidong
    Liotta, Lance A.
    Petricoin, Emanuel F.
    Chandhoke, Vikas
    Bailey, Charles
    Popov, Serguei G.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (42) : 31408 - 31418
  • [15] Transmembrane Signaling Proteoglycans
    Couchman, John R.
    [J]. ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 26, 2010, 26 : 89 - 114
  • [16] INHIBITION OF GLYCOGEN-SYNTHASE KINASE-3 BY INSULIN-MEDIATED BY PROTEIN-KINASE-B
    CROSS, DAE
    ALESSI, DR
    COHEN, P
    ANDJELKOVICH, M
    HEMMINGS, BA
    [J]. NATURE, 1995, 378 (6559) : 785 - 789
  • [17] The heparan sulphate proteoglycan Syndecan-1 (CD138) regulates tumour progression in a 3D model of ductal carcinoma in situ of the breast
    D'Arcy, Christopher
    Zimmermann, Clarissa Constanze
    Espinoza-Sanchez, Nancy Adriana
    Greve, Burkhard
    Schmidt, Annika
    Kiesel, Ludwig
    von Wahlde, Marie-Kristin
    Goette, Martin
    [J]. IUBMB LIFE, 2022, 74 (10) : 955 - 968
  • [18] Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma
    Derksen, PWB
    Keehnen, RMJ
    Evers, LM
    van Oers, MHJ
    Spaargaren, M
    Pals, ST
    [J]. BLOOD, 2002, 99 (04) : 1405 - 1410
  • [19] Transmembrane domains of the syndecan family of growth factor coreceptors display a hierarchy of homotypic and heterotypic interactions
    Dews, Ian C.
    MacKenzie, Kevin R.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (52) : 20782 - 20787
  • [20] Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells
    Ding, K
    Lopez-Burks, M
    Sánchez-Duran, JA
    Korc, M
    Lander, AD
    [J]. JOURNAL OF CELL BIOLOGY, 2005, 171 (04) : 729 - 738
12345678910